- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/50 - Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
Patent holdings for IPC class G01N 33/50
Total number of patents in this class: 22554
10-year publication summary
1629
|
1625
|
1627
|
1912
|
1971
|
1960
|
1836
|
1651
|
1608
|
1248
|
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 18722 |
346 |
President and Fellows of Harvard College | 5693 |
234 |
The Board of Trustees of the Leland Stanford Junior University | 5925 |
182 |
Massachusetts Institute of Technology | 9693 |
179 |
Dana-Farber Cancer Institute, Inc. | 2424 |
168 |
The Johns Hopkins University | 5256 |
150 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3263 |
142 |
Centre National de La Recherche Scientifique | 9432 |
139 |
The General Hospital Corporation | 4491 |
135 |
F. Hoffmann-La Roche AG | 7941 |
127 |
Kyoto University | 2693 |
118 |
Osaka University | 3071 |
118 |
The University of Tokyo | 3837 |
116 |
Immatics Biotechnologies GmbH | 1117 |
115 |
Regeneron Pharmaceuticals, Inc. | 3481 |
97 |
Institut National de La Sante et de La Recherche Medicale (inserm) | 2231 |
96 |
The Brigham and Women's Hospital, Inc. | 2056 |
86 |
Board of Regents, The University of Texas System | 5260 |
85 |
Riken | 1675 |
84 |
Genentech, Inc. | 3650 |
83 |
Other owners | 19754 |